We are live on
!
Find out more
BSA
Braun Stacey Associates Portfolio holdings
AUM
$3.53B
1-Year Est. Return
63.32%
This Fund
S&P 500
This Quarter
Est. Return
+19.45%
1 Year Est. Return
+63.32%
3 Year Est. Return
+230.74%
5 Year Est. Return
+346.7%
10 Year Est. Return
+1,599.29%
AUM
$2.23B
AUM Growth
+$356M
(+19%)
Cap. Flow
-$17.6M
Cap. Flow
% of AUM
-0.79%
Top 10 Holdings %
Top 10 Hldgs %
25.26%
Holding
144
New
17
Increased
80
Reduced
30
Closed
14
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$18.7M |
| 2 |
TWNK
Hostess Brands, Inc. Class A Common Stock
TWNK
|
+$13.6M |
| 3 |
Zimmer Biomet
ZBH
|
+$11.9M |
| 4 |
Host Hotels & Resorts
HST
|
+$8.41M |
| 5 |
Eaton
ETN
|
+$7.38M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NextEra Energy
NEE
|
+$61.1M |
| 2 |
Kimberly-Clark
KMB
|
+$17.8M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$17.8M |
| 4 |
Boston Scientific
BSX
|
+$12.8M |
| 5 |
Roper Technologies
ROP
|
+$12.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.75% |
| 2 | Communication Services | 14.08% |
| 3 | Healthcare | 12.54% |
| 4 | Financials | 12.2% |
| 5 | Industrials | 10.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Elevance Health
ELV
$85.5B
| $225K | 0.01% |
+703
| New | +$216K |
|
|
HOLX
127
DELISTED
Hologic
HOLX
| $215K | 0.01% |
+2,950
| New | +$208K |
|
128
Zillow
Z
$7.56B
| $215K | 0.01% |
+1,660
| New | +$184K |
|
129
West Pharmaceutical
WST
$24.9B
| $211K | 0.01% |
745
| – | – |
|
130
Travelers Companies
TRV
$80.2B
| $207K | 0.01% |
+1,475
| New | +$189K |
|
|
131
Boston Scientific
BSX
$71.5B
| – | – |
-336,282
| Closed | -$12.8M |
|
132
Digital Realty Trust
DLR
$71.7B
| – | – |
-37,613
| Closed | -$5.52M |
|
133
General Mills
GIS
$19.7B
| – | – |
-5,625
| Closed | -$347K |
|
134
IBM
IBM
$224B
| – | – |
-5,282
| Closed | -$614K |
|
|
135
Kimberly-Clark
KMB
$36.5B
| – | – |
-120,485
| Closed | -$17.8M |
|
136
Leidos
LDOS
$17.3B
| – | – |
-7,575
| Closed | -$675K |
|
137
Eli Lilly
LLY
$1.06T
| – | – |
-1,675
| Closed | -$248K |
|
|
138
Roper Technologies
ROP
$39.8B
| – | – |
-30,616
| Closed | -$12.1M |
|
|
139
Vertex Pharmaceuticals
VRTX
$126B
| – | – |
-65,312
| Closed | -$17.8M |
|
140
Wendy's
WEN
$1.46B
| – | – |
-410,080
| Closed | -$9.14M |
|
141
Waste Management
WM
$91B
| – | – |
-3,175
| Closed | -$359K |
|
Similar funds
TYCC
TH
AAP
BCP
TCM
DILIC
KCM
ACM
Braun Stacey Associates's Q4 2020 Portfolio in Review
As of Q4 2020, Braun Stacey Associates held 144 positions worth $2.23B, up 19% from $1.87B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Braun Stacey Associates's Q4 2020 filing shows 17 new, 80 increased, 30 reduced and 14 closed positions. Its largest new stake was Horizon Therapeutics Public Limited Company Ordinary Shares: 251,572 shares worth $18.4M. The largest sale was NextEra Energy, an estimated $61.1M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Communication Services and Healthcare.
- Braun Stacey Associates's largest Q4 2020 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 251,572 shares worth $18.4M.
- Braun Stacey Associates added most to Host Hotels & Resorts in Q4 2020, an estimated $8.41M increase.
- Braun Stacey Associates's biggest Q4 2020 reduction was NextEra Energy, cutting an estimated $61.1M.
- Braun Stacey Associates fully exited Kimberly-Clark in Q4 2020, selling an estimated $17.8M.
- Braun Stacey Associates's ten largest holdings make up 25% of its $2.23B portfolio in Q4 2020.
- Braun Stacey Associates opened 17 new positions and closed 14 in Q4 2020.
- Braun Stacey Associates's portfolio value rose 19% quarter-over-quarter to $2.23B.
Based on Braun Stacey Associates's 13F filing for Q4 2020, filed 3 Feb 2021.